Arthroxib Is A Drug For Rapid And Long-Term Pain Relief In Joint Diseases

(MENAFN- RCTT) The manufacturing enterprise "Academpharm" offers consumers the drug "Arthroxib" for fast and long-term pain relief in diseases of the joints under a manufacturing agreement and is looking for partners to conclude a distribution services agreement. Description For rapid and long-term pain relief in joint conditions (arthrosis, arthritis, spondyloarthritis), highly selective and selective new-generation NSAIDs (non-steroidal anti-inflammatory drugs), such as etoricoxib and meloxicam, are the most effective. They begin to act within 20-30 minutes, last for up to 24 hours when taken just once daily, and minimize gastrointestinal risks.
Major global manufacturers.
1. Organon Co.
Product: Arcoxia (active ingredient: etoricoxib).
Special Features: Organon (a spinoff from the American giant MSD / Merck & Co.) produces the original etoricoxib. The company's products are considered the "gold standard" for the relief of acute joint pain due to their maximum selectivity for the COX-2 enzyme. This allows them to block inflammation without harming the gastric mucosa. 2. Boehringer Ingelheim
Products: Movalis (active ingredient: meloxicam).
Features: This German company is the creator of the original meloxicam. The Movalis line is distinguished by its stepped release forms. For severe exacerbations, ampoules for intramuscular administration are used (they act within 15-20 minutes), after which the patient is gradually switched to the tablet form for maintenance therapy. The drug has a high safety profile for long-term use.
3. Novartis / Sando
Products: Voltaren (Voltaren Prolong/Retard - prolonged-release diclofenac), Ketonal (Ketonal Duo - ketoprofen).
Features: This Swiss manufacturer has modified classic strong analgesics. Their capsules (for example, Ketonal Duo or Voltaren Retard) feature a biphasic release of the substance. The first part of the tablet dissolves instantly (quick onset), while the second is slowly released throughout the day, providing continuous joint pain relief.
4. KRKA
Products: Nalgesin (Nalgesin Forte), Ecoxib (Ecoxib - etoricoxib), Coxamin (Coxamin).
Specifications: A leading Slovenian manufacturer of high-quality generic drugs. KRKA uses European raw materials certified to GMP standards. The company's products are more affordable than their original American counterparts, with comparable effectiveness and duration of action.
Arthroxib, a drug for rapid and long-term pain relief in joint diseases, manufactured by Akademfarm, is intended to relieve symptoms of osteoarthritis (OA), rheumatoid arthritis (RA), and ankylosing spondylitis, as well as to reduce pain and inflammation in acute gouty arthritis and for the short-term treatment of moderate pain following dental surgery.
Composition of the drug.
One tablet contains:
Active ingredient: etoricoxib 30 mg, 60 mg, 90 mg, or 120 mg;
Excipients: microcrystalline cellulose, sodium croscarmellose, magnesium stearate, calcium hydrogen phosphate anhydrous; Shell composition: hypromellose, titanium dioxide (E171), triacetin, lactose monohydrate.
Information about the drug "Arthroxib" for rapid and long-term pain relief for joint diseases can be downloaded from the Company's official website here. Advantages and Innovations In-house production. Highly qualified personnel. Stage of development Already on the market Comments regarding stage of development International nonproprietary name: Etoricoxib Funding source State budged
Internal
IPR status Exclusive rights
Secret know-how
Sector group BioChemTech
Healthcare
Materials
Client information Type R&D institution Year established 2009 NACE keywords C.21.20 - Manufacture of pharmaceutical preparations
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR) 10-20M Already engaged in transnational cooperation Yes Additional comments The Republican production unitary enterprise "ACADEMPHARM" is a dynamically developing, science-intensive state-owned pharmaceutical company. Despite its young age in the pharmaceutical industry, "ACADEMPHARM" has already carved out a niche in the domestic market and continues to expand. The company focuses on unmet medical needs, expanding its product range annually.
Activities:
- Laboratory pharmaceutical research;
- Industrial production of medicinal products and other pharmaceuticals, vitamins, vitamin-mineral and metabolic complexes, and nutraceuticals;
- Contract pharmaceutical manufacturing.
Production lines are equipped with the latest equipment from leading global companies, meeting all GMP requirements.
The pharmaceutical quality system includes good manufacturing practices, quality control, and quality risk management. It is fully documented, and its effectiveness is monitored. All components of the quality system are staffed with competent personnel, sufficient facilities, equipment, and technical resources.
Official website of the Enterprise "Academpharm". Certification standards The Republican production unitary enterprise "AKADEMPHARM" holds national GMP (Good Manufacturing Practice) certificates for the production of all forms of its own products.
The company has implemented and operates a pharmaceutical quality system developed in accordance with the requirements of the national standard TKP 030-2017 (33050) "Good Manufacturing Practice" and international requirements. Languages spoken English
Russian
Information about partnership Type of partnership considered Distribution services agreement
Manufacturing agreement
Type and role of partner sought Consumers interested in purchasing "Arthroxib", a drug for rapid and long-lasting pain relief for joint diseases, under a manufacturing agreement.
Partners interested in purchasing "Arthroxib", a drug for rapid and long-lasting pain relief for joint diseases, under a distribution agreement. Type and size of partner sought > 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor

MENAFN28082026008611018181ID1111592828